NANOVIRICIDES, INC. Logo

NANOVIRICIDES, INC.

Clinical-stage biopharma developing broad-spectrum, nanomedicine-based antivirals.

NNVC | US

Overview

Corporate Details

ISIN(s):
US6300873022
LEI:
Country:
United States of America
Address:
1 CONTROLS DRIVE, 6484 SHELTON

Description

NanoViricides, Inc. is a clinical-stage biopharmaceutical company developing a novel class of nanomedicine-based antiviral therapeutics. The company's proprietary platform technology creates "nanoviricides," which are designed to be broad-spectrum drugs that viruses cannot easily evade through mutation. The technology is biomimetic, mimicking the host cell receptors that viruses use for entry. A nanoviricide is engineered to attract and bind to a virus particle, subsequently trapping and dismantling it to neutralize the threat. The company's development pipeline targets a wide range of viral infections, including respiratory viruses such as RSV, influenza, and coronaviruses, as well as herpesviruses (shingles, cold sores), HIV, and hemorrhagic fever viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-07-21 12:15
NanoViricides in BRileyFBR InfectiousDiseaseSummit
English 12.7 KB
2020-07-13 12:30
NanoViricides Raises $11.5M-Underwritten Offering
English 14.5 KB
2020-07-09 12:15
NanoViricides Prices $10million Public Offering
English 11.9 KB
2020-05-20 12:36
Strong Effectiveness of NanoViricides Drug
English 17.4 KB

Automate Your Workflow. Get a real-time feed of all NANOVIRICIDES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NANOVIRICIDES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NANOVIRICIDES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Evogene Ltd. Logo
A computational biology company using AI to develop life-science products.
Israel
EVGN
Evotec SE Logo
A life science company offering drug discovery and development partnership solutions.
Germany
EVT
EXICURE, INC. Logo
Early-stage biotech developing nucleic acid therapies based on SNA technology.
United States of America
XCUR
EyeGene,Inc Logo
Develops gene/cell therapies for age-related diseases and preventive vaccines.
South Korea
185490
Femtobiomed Inc. Logo
Develops a non-viral intracellular delivery platform for cell and gene therapy.
South Korea
327610
Develops AI data center campuses with co-located hybrid power generation.
United States of America
FRMI
Fluicell AB Logo
A biotech firm creating engineered tissues for regenerative medicine and drug development.
Sweden
FLUI
Foghorn Therapeutics Inc. Logo
Develops medicines targeting the chromatin regulatory system for oncology.
United States of America
FHTX
Fortrea Holdings Inc. Logo
A global CRO providing clinical development and patient access solutions to life sciences.
United States of America
FTRE
FUSION ANTIBODIES PLC Logo
CRO providing end-to-end services for preclinical antibody development.
United Kingdom
FAB

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.